Pfizer Inc. [NYSE: PFE] traded at a high on Friday, posting a 0.38 gain after which it closed the day’ session at $29.27.
The results of the trading session contributed to over 19681008 shares changing hands. Over the past one week, the price volatility of Pfizer Inc. stands at 2.46% while the volatility over the past one month is 1.83%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The market cap for PFE stock reached $165.86 billion, with 5.67 billion shares outstanding and 5.66 billion shares in the current float. Compared to the average trading volume of 31.98M shares, PFE reached a trading volume of 19681008 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Pfizer Inc. [PFE]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PFE shares is $33.11 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PFE stock is a recommendation set at 2.26. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Daiwa Securities have made an estimate for Pfizer Inc. shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on August 07, 2024. The new note on the price target was released on March 22, 2024, representing the official price target for Pfizer Inc. stock. Previously, the target price had yet another raise to $36, while Guggenheim analysts kept a Buy rating on PFE stock.
The Average True Range (ATR) for Pfizer Inc. is set at 0.60, with the Price to Sales ratio for PFE stock in the period of the last 12 months amounting to 2.98. The Price to Book ratio for the last quarter was 1.89, with the Price to Cash per share for the same quarter was set at 1.25. Price to Free Cash Flow for PFE in the course of the last twelve months was 34.48 with Quick ratio for the last quarter at 0.60.
How has PFE stock performed recently?
Pfizer Inc. [PFE] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.49. With this latest performance, PFE shares gained by 1.35% in over the last four-week period, additionally plugging by 4.05% over the last 6 months – not to mention a drop of -14.11% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PFE stock in for the last two-week period is set at 53.36, with the RSI for the last a single of trading hit 55.04, and the three-weeks RSI is set at 52.56 for Pfizer Inc. [PFE]. The present Moving Average for the last 50 days of trading for this stock 29.19, while it was recorded at 29.45 for the last single week of trading, and 28.13 for the last 200 days.
Pfizer Inc. [PFE]: Deeper insight into the fundamentals
Pfizer Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.86.
Earnings analysis for Pfizer Inc. [PFE]
With the latest financial reports released by the company, Pfizer Inc. posted -0.17/share EPS, while the average EPS was predicted by analysts to be reported at -0.34/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 0.17. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PFE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Pfizer Inc. go to 18.60%.
Insider trade positions for Pfizer Inc. [PFE]
There are presently around $67.63%, or 67.66%% of PFE stock, in the hands of institutional investors. The top three institutional holders of PFE stocks are: VANGUARD GROUP INC with ownership of 511.4 million shares, which is approximately 9.0402%. BLACKROCK INC., holding 424.38 million shares of the stock with an approximate value of $$11.87 billion in PFE stocks shares; and BLACKROCK INC., currently with $$8.03 billion in PFE stock with ownership which is approximately 5.0743%.
